Bayer CEO on growth, China & the VW Bug
This article was originally published in Scrip
Executive Summary
Bayer hopes to drive healthcare sales growth through 2016 despite regulatory headwinds in China and the ''dilemma'' of outcomes-based pricing in the pharmaceutical industry.